Invitrogen™ Human AATF Synthetic Peptide

Ref.: BL-RE-175671Manufacturer ref.: PEP-0309 50 μg
€149.00 excl. VAT

AATF Synthetic Peptide, PEP-0309, from Invitrogen.

Gene ID (Enter)
26574
Species
Human
Purification method
Purified
Accession number
Q9NY61
Common name
Human AATF
Brand
Invitrogen

AATF Synthetic Peptide, PEP-0309, from Invitrogen.

AATF Synthetic Peptide, PEP-0309, from Invitrogen.

The protein encoded by this gene was identified on the basis of its interaction with MAP3K12/DLK, a protein kinase known to be involved in the induction of cell apoptosis. This gene product contains a leucine zipper, which is a characteristic motif of transcription factors, and was shown to exhibit strong transactivation activity when fused to Gal4 DNA binding domain. Overexpression of this gene interfered with MAP3K12 induced apoptosis.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15276519
Specifications
Gene ID (Enter)26574
SpeciesHuman
Purification methodPurified
Accession numberQ9NY61
Common nameHuman AATF
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)AATF
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0309
Country of originUnited States
HS customs code3824 99 96 00
A question or a specific configuration?
Contact us for a quote.